APrf Rohit Joshi
School of Medicine
College of Health
Dr. Rohit Joshi is a Medical Oncology Consultant at Calvary Central Districts Hospital, Calvary North Adelaide Hospital and Lyell McEwin Hospital. He works with the Adelaide Oncology and Haematology group at Calvary Hospitals.
Rohit completed his undergraduate training at the Christian Medical College in India, after which he trained in Medical Oncology at the Royal Adelaide Hospital.
Rohit is a Fellow of the Royal Australasian College of Physicians (FRACP), Fellow of the American College of Physicians (FACP) and is certified by the European Society of Medical Oncology (ESMO).
He treats all solid cancer types with major interests in Lung cancer, Breast cancer, Gastro-intestinal cancers (including Colon, Rectum, Pancreas), Kidney cancer and Melanoma.
Rohit is the Director for Cancer Research at Adelaide Oncology and Haematology Group at Calvary Central Districts and Calvary North Adelaide Hospitals. He was the former Director of Cancer Research at the Lyell McEwin Hospital. The research included lung, melanoma, head and neck, colorectal, breast, genitourinary cancers, along with supportive and palliative care studies; including Phase I, Phase II and Phase III studies. He was the Chairperson of the Adelaide Clinical Trials and Education Consortium (ACTEC), which is supported by Cancer Council SA.
He is a Clinical Lecturer at the University of Adelaide and an Adjunct Senior Clinical Fellow at the University of South Australia.
| Date | Position | Institution name |
|---|---|---|
| 2020 - ongoing | Director | Cancer Research SA |
| 2019 - ongoing | Adjunct Senior Clinical Fellow | University of South Australia |
| 2018 - 2022 | Director, Cancer Research | Adelaide Oncology and Haematology |
| 2014 - ongoing | Consultant, Medical Oncology | GenesisCare |
| 2013 - 2017 | Director, Cancer Research and Clinical Trials | SA Health - Lyell McEwin Hospital |
| 2013 - ongoing | Consultant | SA Health - Lyell McEwin Hospital |
| 2010 - ongoing | Clinical Lecturer | University of Adelaide |
| 2008 - 2010 | Assistant Professor | Christian Medical College |
| Language | Competency |
|---|---|
| English | Can read, write, speak, understand spoken and peer review |
| Hindi | Can read, write, speak and understand spoken |
| Panjabi; Punjabi | Can read, write, speak and understand spoken |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2020 | Royal College of Physicians | United Kingdom | FRCP |
| 2015 | American College of Physicians | USA | FACP |
| 2013 | Royal Adelaide and Lyell McEwin Hospitals | Australia | FRACP |
| 1999 - 2002 | Christian Medical College | India | MD |
| 1991 - 1996 | Christian Medical College | India | MBBS |
| Date | Title | Institution name | Country |
|---|---|---|---|
| 2012 | European Certified Medical Oncologist (ECMO) | European Society of Medical Oncology | Switzerland |
| Year | Citation |
|---|---|
| 2026 | Lim, A. H., Nitchingham, D., Bednarz, J., Bills, M., Lanka, L., Allen, B., . . . Nguyen, N. Q. (2026). Combined phosphorus-32 implantation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer: a propensity score–weighted landmark analysis. Gastrointestinal Endoscopy, 103(1), 126-135.e5. Scopus4 WoS1 Europe PMC2 |
| 2026 | Cross, C. B., Bowen, J. M., Leifert, W. R., Beale, D. J., Francois, M., Joshi, R., . . . Wardill, H. R. (2026). Pre-treatment Gut Microbiome and Salivary Metabolome Signatures Associate with Chemotherapy-Induced Cognitive Decline in Women with Breast Cancer: A Prospective Pilot Study. . Cancer letters, 218234. |
| 2025 | André, T., Elez, E., Lenz, H. J., Jensen, L. H., Touchefeu, Y., Van Cutsem, E., . . . Lonardi, S. (2025). Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial. Lancet, 405(10476), 383-395. Scopus89 WoS88 Europe PMC68 |
| 2024 | Leighl, N. B., Akamatsu, H., Lim, S. M., Cheng, Y., Minchom, A. R., Marmarelis, M. E., . . . Zurawski, B. (2024). Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study. Journal of Clinical Oncology, 42(30), 3593-3605. Scopus76 WoS84 Europe PMC69 |
| 2024 | Lim, A. H. W., Zobel, J., Bills, M., Hsieh, W., Crouch, B., Joshi, R., . . . Nguyen, N. Q. (2024). The impact of combined chemotherapy and intra-tumoural injection of Phosphorus-32 Microparticles on vascularity in locally advanced pancreatic carcinoma. Cancers, 16(19), 1-14. Scopus6 WoS6 Europe PMC3 |
| 2024 | Andre, T., Elez, E., Van Cutsem, E., Jensen, L. H., Bennouna, J., Mendez, G., . . . Lonardi, S. (2024). Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal Cancer. New England Journal of Medicine, 391(21), 2014-2026. Scopus107 WoS118 Europe PMC90 |
| 2023 | Murray, J., Bennett, H., Selva Nayagam, S., Joshi, R., Bezak, E., & Perry, R. (2023). Impact of aerobic training on cardiovascular function, fitness, and patient reported outcomes during anthracycline chemotherapy: a case series in women with breast cancer. Integrative Cancer Therapies, 22, 1-13. |
| 2023 | Obrocea, M., Seidl, B., Joshi, R., Moore, M., Vitoc, V., Yao, B., & Gryaznov, S. (2023). A phase 2, multi-center, open-label, dose-finding study evaluating telomere targeting agent THIO sequenced with cemiplimab in patients with advanced NSCLC. CANCER RESEARCH, 83(8), 2 pages. |
| 2023 | Rainey, N., Joshi, R., Chiu, J., Chen, A., Wang, H., Odegard, J., . . . Adams, S. (2023). A phase 2 randomized study of magrolimab combination therapy in adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC): ELEVATE-TNBC. JOURNAL OF CLINICAL ONCOLOGY, 41(16_SUPPL), TPS1130. |
| 2023 | Rainey, N., Joshi, R., Chiu, J. W. Y., Chen, A., Wang, H., Odegard, J., . . . Adams, S. (2023). A phase 2, randomized study of magrolimab combination therapy in adult patients with unresectable locally advanced or metastatic triple-negative breast cancer. CANCER RESEARCH, 83(5), 2 pages. WoS1 |
| 2023 | He, K., Carbone, D. P., Mckean, M., Balaraman, R., Shah, S., Arrowsmith, E., . . . Li, T. (2023). Safety and clinical activity of target-preserving anti-CTLA-4 antibody ONC-392 as monotherapy in NSCLC patients who progressed on PD(L)1-targeted immunotherapy.. JOURNAL OF CLINICAL ONCOLOGY, 41(16_SUPPL), 9024. WoS2 |
| 2023 | Lee, C. K., Soon, Y. Y., Jeffree, R. L., Joshi, R., Koh, E. S., Lam, W. S., . . . John, T. (2023). Management paradigm of central nervous system metastases in NSCLC: an Australian perspective. JTO Clinical and Research Reports, 4(9), 1-10. |
| 2022 | Li, M., Reintals, M., D'Onise, K., Farshid, G., Holmes, A., Joshi, R., . . . Roder, D. M. (2022). Investigating the breast cancer screening-treatment-mortality pathway of women diagnosed with invasive breast cancer: Results from linked health data.. European journal of cancer care, 31(1), 12 pages. Scopus4 WoS3 Europe PMC2 |
| 2022 | Skrabal, R. X., Gunn, K. M., Suppiah, V., Patterson, P., Boyle, T., Carrington, C., . . . Olver, I. (2022). A smartphone program to support adherence to oral chemotherapy in people with cancer: proof-of-concept trial. Asia-Pacific Journal of Clinical Oncology, 18(5), e378-e387. Scopus3 WoS3 Europe PMC3 |
| 2022 | Johnson, M. L., Fox, W., Lee, Y. -G., Lee, K. H., Ahn, H. K., Kim, Y. -C., . . . Joshi, R. (2022). ARC-7: Randomized phase 2 study of domvanalimab + zimberelimab ± etrumadenant versus zimberelimab in first-line, metastatic, PD-L1-high non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology, 40(36_suppl), 397600. |
| 2022 | Yong, C. H., Gupta, A., & Joshi, R. (2022). CSCO breast cancer management guidelines 2022: Australian perspective. Translational Breast Cancer Research, 3, 4 pages. |
| 2022 | Telli, M. L., Wapnir, I., Devitt, B., Cuff, K., Soliman, H., Vinayak, S., . . . Joshi, R. (2022). Durable responses with intratumoral electroporation of plasmid interleukin-12 plus pembrolizumab in patients with advanced triple-negative breast cancer: Cohort 1 update from KEYNOTE-890. CANCER RESEARCH, 82(4), 3 pages. |
| 2022 | Telli, M., Devitt, B., Cuff, K., Vinayak, S., Nanda, R., Montero, A. J., . . . Joshi, R. (2022). Trial in progress: Phase 2 study of intratumoral plasmid interleukin-12 (tavokinogene telseplasmid; TAVO™) plus electroporation in combination with pembrolizumab with or without chemotherapy in patients with inoperable locally advanced or metastatic triple-negative breast cancer (KEYNOTE-890/OMS-I141). CANCER RESEARCH, 82(4), 3 pages. WoS2 |
| 2021 | Alawawdeh, A., Krishnan, T., Roy, A., Karapetis, C., Joshi, R., Singhal, N., & Price, T. (2021). Curative therapy for rectal cancer. Expert Review of Anticancer Therapy, 21(2), 193-203. Scopus8 WoS7 Europe PMC6 |
| 2021 | Li, M., Roder, D., D'Onise, K., Walters, D., Farshid, G., Buckley, E., . . . Olver, I. (2021). Female breast cancer treatment and survival in South Australia: Results from linked health data.. Eur J Cancer Care (Engl), 30(5), 1-12. Scopus3 WoS4 Europe PMC3 |
| 2020 | Gupta, A., & Joshi, R. (2020). Breast cancer diagnosis and treatment: Asian perspective. TRANSLATIONAL BREAST CANCER RESEARCH, 1, 3 pages. WoS1 |
| 2020 | McCaffrey, N., Asser, T., Fazekas, B., Muircroft, W., Agar, M., Clark, K., . . . Currow, D. C. (2020). Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide. BMC Cancer, 20(1), 9 pages. Scopus9 WoS9 Europe PMC10 |
| 2020 | Li, M., Roder, D., D'Onise, K., Walters, D., Farshid, G., Buckley, E., . . . Olver, I. (2020). Monitoring TNM stage of female breast cancer and survival across the South Australian population, with national and international TNM benchmarking: A population-based cohort study. BMJ Open, 10(6), e037069. Scopus7 WoS7 Europe PMC4 |
| 2020 | Shepherd, A. R. H., Joshi, R., Tan, C. P., Cohen, P., & Brook, N. R. (2020). Inferior vena cava thrombectomy following complete response to nivolumab/ipilimumab for metastatic renal cell carcinoma. ANZ Journal of Surgery, 90(7-8), 1517-1519. Scopus8 WoS8 Europe PMC8 |
| 2019 | Tan, J. L., Mugwagwa, A. N., Cieslik, L., & Joshi, R. (2019). Nivolumab-induced myocarditis complicated by complete atrioventricular block in a patient with metastatic non-small cell lung cancer. BMJ Case Reports, 12(7), 229963-1-229963-5. Scopus10 WoS7 Europe PMC8 |
| 2019 | Roder, D., Karapetis, C. S., Olver, I., Keefe, D., Padbury, R., Moore, J., . . . Price, T. (2019). Time from diagnosis to treatment of colorectal cancer in a South Australian clinical registry cohort: how it varies and relates to survival.. BMJ open, 9(9), 1-11. Scopus30 WoS22 Europe PMC24 |
| 2019 | Gupta, A., & Joshi, R. (2019). Improving chemotherapy outcome in early breast cancer. Gland Surgery, 8(5), 585-587. |
| 2019 | Parente, P., Chan, B. A., Hughes, B. G. M., Jasas, K., Joshi, R., Kao, S., . . . Stone, E. (2019). Patterns of care for stage III non–small cell lung cancer in Australia. Asia Pacific Journal of Clinical Oncology, 15(3), 93-100. Scopus5 WoS4 Europe PMC5 |
| 2018 | Townsend, A., Tebbutt, N., Karapetis, C., Cooper, P., Singhal, N., Yeend, S., . . . Price, T. (2018). Phase IB/II study of second-line therapy with Panitumumab, Irinotecan, and Everolimus (PIE) in KRAS wild-type metastatic colorectal cancer. Clinical Cancer Research, 24(16), 3838-3844. Scopus8 WoS6 Europe PMC5 |
| 2018 | Adelson, P., Fusco, K., Karapetis, C., Wattchow, D., Joshi, R., Price, T., . . . Roder, D. (2018). Use of guideline-recommended adjuvant therapies and survival outcomes for people with colorectal cancer at tertiary referral hospitals in South Australia. Journal of Evaluation in Clinical Practice, 24(1), 135-144. Scopus16 WoS14 Europe PMC15 |
| 2017 | Currow, D., Watts, G., Johnson, M., McDonald, C., Miners, J., Somogyi, A., . . . Ekström, M. (2017). A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion and Morphine Sulfate (BEAMS) study protocol. BMJ Open, 7(7), e018100-1-e018100-18. Scopus29 WoS30 Europe PMC22 |
| 2017 | Roder, D., Farshid, G., Kollias, J., Koczwara, B., Karapetis, C., Adams, J., . . . Price, T. (2017). Female breast cancer management and survival: the experience of major public hospitals in South Australia over 3 decades-trends by age and in the elderly. Journal of Evaluation in Clinical Practice, 23(6), 1433-1443. Scopus6 WoS7 Europe PMC5 |
| 2017 | Aguirre, V. J., Barnett, D., Burdett, N., Joshi, R., & Viana, F. F. (2017). Video-assisted thoracoscopy in the management of intrapleural extravasation of cytotoxic chemotherapy.. Thoracic cancer, 8(4), 363-364. Scopus3 WoS3 Europe PMC2 |
| 2017 | Buckley, E., Farshid, G., Gill, G., Kollias, J., Koczwara, B., Karapetis, C., . . . Roder, D. (2017). Assessing impact of organised breast screening across small residential areas-development and internal validation of a prediction model. European Journal of Cancer Care, 26(4), e12673-1-e12673-8. |
| 2017 | Roder, D., Farshid, G., Gill, G., Kollias, J., Koczwara, B., Karapetis, C., . . . Beckmann, K. (2017). Breast cancer screening-opportunistic use of registry and linked screening data for local evaluation. Journal of Evaluation in Clinical Practice, 23(3), 508-516. Scopus4 WoS2 Europe PMC2 |
| 2016 | Roder, D., Karapetis, C., Wattchow, D., Moore, J., Singhal, N., Joshi, R., . . . Price, T. (2016). Colorectal cancer treatment and survival over three decades at four major public hospitals in South Australia: trends by age and in the elderly. European Journal of Cancer Care, 25(5), 753-763. Scopus4 WoS4 Europe PMC4 |
| 2016 | Beckmann, K. R., Bennett, A., Young, G. P., Cole, S. R., Joshi, R., Adams, J., . . . Roder, D. (2016). Sociodemographic disparities in survival from colorectal cancer in South Australia: a population-wide data linkage study. BMC Health Services Research, 16(1), 1-14. Scopus54 WoS50 Europe PMC42 |
| 2015 | Roder, D., Karapetis, C., Wattchow, D., Moore, J., Singhal, N., Joshi, R., . . . Price, T. (2015). Colorectal cancer treatment and survival : the experience of major public hospitals in South Australia over three decades. Asian Pacific Journal of Cancer Prevention, 16(6), 2431-2440. Scopus28 Europe PMC29 |
| 2015 | Roder, D., Karapetis, C., Wattchow, D., Moore, J., Singhal, N., Joshi, R., . . . Price, T. (2015). Metastatic colorectal cancer treatment and survival: the experience of major public hospitals in South Australia over three decades. Asian Pacific Journal of Cancer Prevention, 16(14), 5923-5931. Scopus12 Europe PMC3 |
| 2015 | Joshi, R., & Joshi, R. (2015). Deconstructing epidemiology. CHRISMED Journal of Health and Research, 2(1), 3. |
| 2014 | Vatandoust, S., Joshi, R., Pitman, K., Esterman, A., Broadbridge, V., Adams, J., . . . Price, T. (2014). A descriptive study of persistent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer. Supportive Care in Cancer, 22(2), 513-518. Scopus29 WoS26 Europe PMC20 |
| 2013 | Butt, S., Vatandoust, S., Kleinig, T., Adams, J., Basu, S., Otto, G., & Joshi, R. (2013). Anti-Ri antibody-associated paraneoplastic brainstem encephalitis successfully treated after treating the underlying malignancy with letrozole. Internal Medicine Journal, 2013(5), 605-606. Scopus2 WoS2 |
| 2013 | Grover, S., Leong, D., Chakrabarty, A., Joerg, L., Kotasek, D., Cheong, K., . . . Selvanayagam, J. (2013). Left and right ventricular effects of anthracycline and trastuzumab chemotherapy: A prospective study using novel cardiac imaging and biochemical markers. International Journal of Cardiology, 168(6), 5465-5467. Scopus102 WoS96 Europe PMC86 |
| 2013 | Valsalan, R., Joshi, R., Adams, J., & Arstall, M. (2013). Cardiac failure with bevacizumab: An oversight. Asia Pacific Journal of Clinical Oncology, Online(1), 1-2. |
| 2013 | Joshi, R. (2013). Adjuvant colon cancer chemotherapy: is there an Indian standard of care?. South Asian journal of cancer, 2(2), 70-71. Europe PMC1 |
| 2013 | Grover, S., DePasquale, C., Srinivasan, G., Leong, D. P., Chakrabarty, A., Cheong, K. A., . . . Selvanayagam, J. (2013). Contemporary breast cancer chemotherapy leads to persistent late right ventricular myocardial dysfunction: a prospective multi-centre study. Journal of Cardiovascular Magnetic Resonance, 15, P164. |
| 2013 | Grover, S., DePasquale, C., Srinivasan, G., Leong, D. P., Chakrabarty, A., Cheong, K. A., . . . Selvanayagam, J. (2013). Early and late left ventricular effects of breast cancer chemotherapy: a prospective multi-centre study using advanced cardiac imaging. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 15(Suppl 1), P142. Europe PMC1 |
| 2012 | Vatandoust, S., Joshi, R., Broadbridge, V., Pittman, K. B., Adams, J., Singhal, N., . . . Price, T. J. (2012). Persistent oxaliplatin (OX) induced peripheral neuropathy in patients (pts) with colorectal cancer: A descriptive study.. Journal of Clinical Oncology, 30(15_suppl), e19513. |
| 2012 | Grover, S., DePasquale, C., Leong, D. P., Chakrabarty, A., Cheong, K. A., Kotasek, D., . . . Selvanayagam, J. (2012). Early cardiac changes following anthracycline chemotherapy in breast cancer: a prospective multi-centre study using advanced cardiac imaging and biochemical markers. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 14(Suppl 1), P181. Europe PMC2 |
| 2012 | Grover, S., De Pasquale, C., Leong, D., Chakrabathy, A., Cheong, K., Kotasek, D., . . . Selvanayagam, J. (2012). Biventricular Ventricular Dysfunction Following Administration of Anthracycline (AC) Chemotherapy In Breast Cancer: A Prospective Multi-Centre Study Using Advanced Cardiac Imaging and Biochemical Markers. Heart, Lung and Circulation, 21, S187. |
| 2012 | Vatandoust, S., Joshi, R., & Price, T. (2012). Guillain-Barré syndrome in colorectal cancer. Asia Pacific Journal of Clinical Oncology, 8(2), 205-208. Scopus4 WoS3 Europe PMC3 |
| 2008 | Singhal, N., Hissaria, P., Joshi, R., & Nayagam, S. (2008). Inflammatory myopathy and cancer: Rare association of seminoma testes and polymyositis. Internal Medicine Journal, 38(4), 295-297. Scopus3 WoS1 Europe PMC2 |
| 2008 | Joshi, R., Mammen, K., & Pawar, B. (2008). Successful renal transplantation after two separate urinary tract malignancies. Indian Journal of Urology, 24(2), 256-257. Scopus3 WoS2 Europe PMC2 |
| 2007 | Joshi, R., Olver, I., Keefe, D., Marafioti, T., & Smith, K. (2007). A phase I study to assess the safety and activity of topical lovastatin (FP252S) for the prevention of chemotherapy-induced alopecia. Supportive Care in Cancer, 15(9), 1109-1112. Scopus8 WoS5 Europe PMC4 |
| - | Joshi, R., Hocking, C., O’Neill, S., Singhal, N., Kee, M., & Keefe, D. M. (2022). A Prospective Audit of Inpatient Medical Oncology Consultation Patterns in a Tertiary Teaching Hospital in South Australia. Global Journal Of Epidemiology and Public Health, 1(2), 42-47. |
| Year | Citation |
|---|---|
| 2018 | Joshi, R., & Hong, H. W. (2018). Ascites. In Mascc Textbook of Cancer Supportive Care and Survivorship (pp. 437-443). Springer International Publishing. DOI |
| 2010 | Joshi, R. (2010). Ascites. In The MASCC Textbook of Cancer Supportive Care and Survivorship (pp. 261-265). Springer US. DOI |
| Year | Citation |
|---|---|
| 2024 | Lenz, H. J., Lonardi, S., Elez, E., Van Cutsem, E., Jensen, L. H., Bennouna, J., . . . Andre, T. (2024). Nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) as first-line (1L) treatment for microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): Expanded efficacy analysis from CheckMate 8HW.. In Journal of Clinical Oncology Vol. 42 (pp. 3503). ELECTR NETWORK: LIPPINCOTT WILLIAMS & WILKINS. DOI Scopus14 WoS11 |
| 2022 | Ly, Y. J., Hocking, C., Joshi, R., Patel, D., Hong, H., McGregor, M., . . . Kwatra, V. (2022). Real-world comparative data on addition of Atezolizumab to platinum-doublet chemotherapy in extensive stage small cell lung cancer - A single South Australian institution experience. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 18 (pp. 163-164). WILEY. |
| 2022 | Ciuleanu, T. -E., Joshi, R., Gryaznov, S., Vitoc, V., & Obrocea, M. (2022). A phase II, multicenter, open-label, dose-finding study evaluating THIO sequenced with cemiplimab in patients with advanced NSCLC. In ANNALS OF ONCOLOGY Vol. 33 (pp. S1094). ELECTR NETWORK: ELSEVIER. DOI WoS1 |
| 2022 | Joshi, R., Goh, J., Joubert, W., Kwarta, V., Okera, M., Bishnoi, S., . . . Gargosky, S. (2022). CLINICAL UPDATE FROM A PHASE 1, FIRST-IN-HUMAN, OPEN-LABEL SINGLE AGENT STUDY OF SUPLEXA THERAPEUTIC CELLS IN PATIENTS WITH METASTATIC SOLID TUMOURS AND HAEMATOLOGIC MALIGNANCIES. In JOURNAL FOR IMMUNOTHERAPY OF CANCER Vol. 10 (pp. A663). BMJ PUBLISHING GROUP. DOI |
| 2022 | Hays, J., Li, T., Chen, H., Zahrah, G., Frank, R., Hamm, J., . . . O'Malley, D. (2022). SAFETY AND CLINICAL ACTIVITIES OF THE ACID PH-SENSITIVE ANTI-CTLA-4 MAB ONC-392 IN OVARIAN CANCER PATIENTS. In JOURNAL FOR IMMUNOTHERAPY OF CANCER Vol. 10 (pp. A591). BMJ PUBLISHING GROUP. DOI |
| 2020 | Telli, M. L., Wapnir, I., Devitt, B., Cuff, K., Soliman, H., Vinayak, S., . . . Joshi, R. (2020). Phase 2, open-label study of intratumoral tavokinogene telseplasmid (tavo) plus electroporation in combination with intravenous pembrolizumab therapy in patients with inoperable locally advanced or metastatic triple-negative breast cancer (mTNBC) (KEYNOTE-890/OMS-I141). In CANCER RESEARCH Vol. 80 (pp. 3 pages). San Antonio, TX: AMER ASSOC CANCER RESEARCH. DOI WoS8 |
| 2020 | Chan, M. M., Hocking, C., Joshi, R., Patel, D., Singhal, N., McGregor, M., . . . Kwatra, V. (2020). A shift towards virtual multidisciplinary tumour board meeting during COVID 19 pandemic - A South Australian Survey. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 16 (pp. 167). WILEY. |
| 2017 | Townsend, A. R., Hardingham, J., Tebbutt, N. C., Karapetis, C. S., Singhal, N., Joshi, R., . . . Price, T. J. (2017). A phase Ib/II study of second-line therapy with panitumumab, irinotecan and everolimus (PIE) in metastatic colorectal cancer (mCRC) with KRAS wild type (WT): Biomarker substudy.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 35 (pp. 1 page). Chicago, IL: AMER SOC CLINICAL ONCOLOGY. DOI WoS1 |
| 2015 | Patel, D., Abdghan, N., Kerr, K. -A., Row, J., Adams, J., & Joshi, R. (2015). Clinical presentation and management pattern of venous thrombosis in patients receiving chemotherapy. In ANNALS OF ONCOLOGY Vol. 26 (pp. 116-117). Singapore, SINGAPORE: OXFORD UNIV PRESS. |
| 2007 | Joshi, R., O'Neill, S., & Keefe, D. (2007). A prospective audit of inpatient medical oncology consultation patterns in a tertiary teaching hospital in South Australia. In ANNALS OF ONCOLOGY Vol. 18 (pp. 196-197). Lugano, SWITZERLAND: OXFORD UNIV PRESS. |
| Year | Citation |
|---|---|
| 2022 | Cilento, M. A., Chalwin, R., Hocking, C., Chan, L., Smithers, L., & Joshi, R. (2022). MORBIDITY AND MORTALITY OF ONCOLOGY PATIENTS ADMITTED TO AN INTENSIVE CARE UNIT. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. |
| 2019 | Fernandez-Penas, P., Carlino, M., Atkinson, V., Telli, M., Joshi, R., Thomas, S., . . . Algazi, A. (2019). Intratumoral IL-12 plus pembrolizumab combination therapy in treatment refractory solid tumors: a safety and biomarker analysis. Poster session presented at the meeting of JOURNAL FOR IMMUNOTHERAPY OF CANCER. BMJ PUBLISHING GROUP. |
| 2018 | Telli, M., Wapnir, I., Vinayak, S., Soliman, H., Cuff, K., Devitt, B., . . . Joshi, R. (2018). A phase 2 study of intratumoral tavokinogene telseplasmid (tavo) plus electroporation with pembrolizumab in patients with inoperable locally advanced or metastatic triple-negative breast cancer. Poster session presented at the meeting of San Antonio Breast Cancer Symposium. San Antonio, Texas. |
| 2016 | Doherty, T., Hislop, C., Fitzgerald, M., Campbell, J., Poprawski, D., Roberts, S., . . . Koczwara, B. (2016). CONTEXT IMPACTS OUTCOMES: LESSONS LEARNT FROM THE SOUTH AUSTRALIAN SURVIVORSHIP FRAMEWORK PILOT IMPLEMENTATION. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL. |
| 2016 | Townsend, A., Tebbutt, N., Karapetis, C., Cooper, P., Singhal, N., Yeend, S., . . . Price, T. J. (2016). A phase IB/II study of second-line therapy with panitumumab, irinotecan and everolimus (PIE) in metastatic colorectal cancer (mCRC) with KRAS wild type (WT). Poster session presented at the meeting of Annals of Oncology. Copenhagen, DENMARK: OXFORD UNIV PRESS. DOI Scopus1 WoS1 |
| 2016 | Joshi, R., Connolly, P., Foo, T., & Rowe, J. (2016). Hypomagnesaemia in the context of cetuximab/panitumumab and proton pump inhibitor therapy. Poster session presented at the meeting of ANNALS OF ONCOLOGY. OXFORD UNIV PRESS. |
| 2013 | Vatandoust, S., Joshi, R., Pittman, K., Esterman, A., Broadbridge, V., Adams, J., . . . Price, T. (2013). A descriptive study of persistent oxaliplatin induced peripheral neuropathy in patients with colorectal cancer. Poster session presented at the meeting of Abstracts of the Medical Oncology Group of Australia Incorporated Annual Scientific Meeting, Blood, Biomarkers and Beyond, 31 July - 2 August 2013, as published in Asia-Pacific Journal of Clinical Oncology. Melbourne, Victoria: Wiley-Blackwell. DOI |
| 2013 | Townsend, A. R., Pirc, L., Cooper, P., Tebbutt, N. C., Karapetis, C. S., Singhal, N., & Price, T. J. (2013). A phase Ib study of second-line therapy with panitumumab, irinotecan, and everolimus (PIE) in metastatic colorectal cancer (mCRC) with KRAS wild type (WT).. Poster session presented at the meeting of JOURNAL OF CLINICAL ONCOLOGY. Chicago, IL: LIPPINCOTT WILLIAMS & WILKINS. WoS2 |
| 2012 | Grover, S., Depasquale, C., Leong, D., Cheong, K., Kotasek, D., Joshi, R., . . . Selvanayagam, J. (2012). Biventricular dysfunction following administration of anthracycline based chemotherapy in breast cancer: a prospective multi-centre study using advanced cardiac imaging and biochemical markers. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Munchen, GERMANY: OXFORD UNIV PRESS. |
| 2012 | Vatandoust, S., Joshi, R., Broadbridge, V., Pittman, K. B., Adams, J., Singhal, N., . . . Price, T. J. (2012). Persistent oxaliplatin (OX) induced peripheral neuropathy in patients (pts) with colorectal cancer: A descriptive study.. Poster session presented at the meeting of JOURNAL OF CLINICAL ONCOLOGY. Chicago, IL: AMER SOC CLINICAL ONCOLOGY. |
| 2011 | Cheng, H. B., To, T., Joshi, R., & Singhal, N. (2011). OUTCOMES OF GERIATRIC ASSESSMENT FOR OLDER LUNG CANCER PATIENTS FROM A DEDICATED GERIATRIC ONCOLOGY PROGRAM. Poster session presented at the meeting of JOURNAL OF THORACIC ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS. WoS2 |